in the horse: A PK/PD study
The pharmacokinetic/pharmacodynamic profile of tepoxalin and RWJ-20142 suggest that the drug is a selective COX-1 inhibitor in horses, with no significant anti-inflammatory activity.
M. Giorgi, B. Cuniberti, G. Ye et al.
· 0 citations